5 completed, 2 recruiting, 1 terminated, 1 unknown. 9 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 9 | Completed 5, Recruiting 2, Terminated 1, Unknown 1 |
Follow Thromboembolism: new trials by email Literature Review of Thromboembolism trials Research Report on Thromboembolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Apixaban in Thrombocytopenia Apixaban - Deep Vein Thrombosis, Pulmonary Embolism and Thrombosis | Early Phase 1 | Recruiting | Rushad Patell | 30 | 2025-02-28 | 2026-04-15 |
| Supplemental Oxygen in Pulmonary Embolism (SO-PE) Oxygen Therapy, Non-rebreather mask - Pulmonary Embolism, Venous Thromboembolism | Early Phase 1 | Recruiting | Massachusetts General Hospital | 80 | 2023-10-01 | 2025-06-15 |
| Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease Apixaban 2.5 milligram, Placebo Oral Tablet - IBD, Venous Thromboembolism | Early Phase 1 | Unknown | McMaster University | 60 | 2021-09-01 | 2024-01-05 |
| Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity Aspirin 81 mg, Placebo - Venous Thromboembolism, Postpartum Period | Early Phase 1 | Completed | University of Calgary | 257 | 2020-10-07 | 2023-09-13 |
| Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin Standard heparin dose, Real time heparin dose adjustment - Deep Vein Thrombosis, Pulmonary Embolism | Early Phase 1 | Completed | University of Utah | 20 | 2018-03-23 | 2023-05-17 |
| Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin Real time heparin dose adjustment, Standard heparin dose - Deep-Venous Thrombosis, Pulmonary Embolism | Early Phase 1 | Completed | University of Utah | 20 | 2016-11-10 | 2019-07-24 |
| Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose Real time enoxaparin dose adjustment, Standard enoxaparin dose - Deep Venous Thrombosis, Pulmonary Embolus | Early Phase 1 | Completed | University of Utah | 116 | 2016-03-01 | 2019-05-24 |
| Statin Use in Patients With Acute VTE Atorvastatin, Anticoagulation Therapy - Venous Thromboembolism | Early Phase 1 | Terminated | Ohio State University | 21 | 2015-01-01 | 2020-10-19 |
| Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis Aspirin, Simvastatin, Observation - Solid Tumor, Cancer | Early Phase 1 | Completed | Case Comprehensive Cancer Center | 17 | 2014-12-30 | 2019-05-08 |
Venous Thromboembolism (9) · Pulmonary Embolism (7) · Venous Thrombosis (5) · Thrombosis (2) · Colitis, Ulcerative (1) · Crohn Disease (1) · Neoplasms (1) · Postpartum Hemorrhage (1) · Pre-Eclampsia (1) · Thrombocytopenia (1) · Thrombophilia (1) · Ventricular Dysfunction, Right (1)
Cardiovascular Diseases (9) · Embolism and Thrombosis (9) · Vascular Diseases (9) · Embolism (7) · Lung Diseases (7) · Respiratory Tract Diseases (7) · Thrombosis (4) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Blood Platelet Disorders (1) · Colitis (1) · Colonic Diseases (1) · Cytopenia (1) · Digestive System Diseases (1)
Aspirin (2) · Anticoagulation Bridge (1) · Atorvastatin (1) · Observation (1) · Oxygen (1) · Rivaroxaban (1) · Simvastatin (1) · Warfarin (1) · apixaban (1)
University of Utah (3) · Case Comprehensive Cancer Center (1) · Massachusetts General Hospital (1) · McMaster University (1) · Ohio State University (1) · Rushad Patell (1) · University of Calgary (1)
United States (7) · Canada (2) · France (1) · Ireland (1) · Netherlands (1)
Alok A Khorana, MD (1) · Anne Prazak, PharmD (1) · Christopher Kabrhel, MD, MPH (1) · Christopher Puccini, MD (1) · Corinne Bertolaccini, PharmD (1) · Leslie Skeith, MD (1) · Marc Rodger, MD (1) · Rushad Patell, MD (1) · Tzu-Fei Wang, MD (1)
PMID 31116389, PMID 33086312, PMID 33196511, PMID 33779986, PMID 39238110, PMID 39532350, PMID 39827892, PMID 41821307